The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 31, 2011

Filed:

Sep. 20, 2005
Applicants:

Rajender Kamboj, Burnaby, CA;

Zaihui Zhang, Vancouver, CA;

Jianmin Fu, Coquitlam, CA;

Serguei Sviridov, Burnaby, CA;

Shaoyi Sun, Coquitlam, CA;

Mehran Seid Bagherzadeh, North Vancouver, CA;

Vandna Raina, Burnaby, CA;

Duanjie Hou, Burnaby, CA;

Sultan Chowdhury, Scarborough, CA;

Shifeng Liu, Port Coquitlam, CA;

Vishnumurthy Kodumuru, Burnaby, CA;

Nagasree Chakka, Burnaby, CA;

Inventors:

Rajender Kamboj, Burnaby, CA;

Zaihui Zhang, Vancouver, CA;

Jianmin Fu, Coquitlam, CA;

Serguei Sviridov, Burnaby, CA;

Shaoyi Sun, Coquitlam, CA;

Mehran Seid Bagherzadeh, North Vancouver, CA;

Vandna Raina, Burnaby, CA;

Duanjie Hou, Burnaby, CA;

Sultan Chowdhury, Scarborough, CA;

Shifeng Liu, Port Coquitlam, CA;

Vishnumurthy Kodumuru, Burnaby, CA;

Nagasree Chakka, Burnaby, CA;

Assignee:

Xenon Pharmaceuticals Inc., Burnaby, BC, CA;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 401/04 (2006.01); A61K 31/501 (2006.01); A61P 9/00 (2006.01); A61P 3/10 (2006.01); A61P 3/04 (2006.01); A61P 3/00 (2006.01); C07D 213/26 (2006.01); A61K 31/45 (2006.01);
U.S. Cl.
CPC ...
Abstract

Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I): Formula (I) where x, y, G, J, L, M, V, W, R, R, R, R, R, R, R, R, R, R, and Rare defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.


Find Patent Forward Citations

Loading…